ISSN: 2581-5288
Journal of Gynecological Research and Obstetrics
Research Article       Open Access      Peer-Reviewed

Complications of Robotic Surgery in Oncological Gynecology: The Experience of the Brazilian National Institute of Cancer

Érico Lustosa Ferreira1, Julio C Nunes2, Mariana Zandoná2, Caio Perret2, Rossano Fiorelli3* and Agostinho Manuel da Silva Ascenção3

1Senior Staff of the Brazilian National Institute of Cancer (INCA), Brazil
2Medical students at UNIRIO, Department of Surgery, Brazil
3Ph.D. Professor and Advisor in the surgery post-graduation program (UNIRIO), Brazil
*Corresponding author: Rossano Fiorelli, M.D. PhD, Hospital Universitário Gaffrée e Guinle. Departamento de Cirurgia. Rua Mariz e Barros, 775 – Rio de Janeiro, RJ, Brazil, Tel: +55 (21) 2264-4339; E-mail: rossaniofiorelli@hotmail.com
Received: 04 April, 2019 | Accepted: 23 May, 2019 | Published: 24 May, 2019

Cite this as

Ferreira ÉL, Nunes JC, Zandoná M, Perret C, Fiorelli R, et al. (2019) Complications of Robotic Surgery in Oncological Gynecology: The Experience of the Brazilian National Institute of Cancer. J Gynecol Res Obstet 5(2): 022-025. DOI: 10.17352/jgro.000065

Introduction

The number of surgeries performed with robotic equipment has increased ever since its release by the Food and Drug Administration (FDA) in 2005 [1].

Robotic surgery is well accepted and seems to be as effective as laparoscopy in the treatment of endometrial and cervix cancers [2,3]. Some of the advantages of using this method over the traditional laparoscopic technique include 3D visualization, tremor filtration, greater dexterity, better ergonomics, lower blood loss and lower post-operative pain index [4].

In spite of some known limitations, such as the limited view of the 4 surgical quadrants when using Da Vinci® series S and Si, robotic surgery is now widely used in the United States [5]. Furthermore, this limitation has been correct by the newest Da Vinci® series XI, increasing the effectiveness of the method. With this updates in technology, the American Society of Gynecologic Oncology (SGO) now recognizes robotic surgery as a changer in gynecologic cancer treatment paradigms [6].

To the present moment, 3200 robotic platform exist in the world (2223 in the USA, 549 in Europe and 494 in the rest of the world). Also, in the United States 95% of the gynecologic oncologists have these platforms in their institutions and have been trained to use them [7].

The objective of this study is to assess the complications and outcomes of gynecological cancer cases treated with robotic surgery at the Brazilian National Institute of Cancer (INCA). The safety of the procedures was evaluated by detecting early and late complications of the procedures, thus determining morbidity and mortality.

Methodology

A descriptive cross-sectional, quantitative and retrospective study, with quantitative and non-experimental research design, was conducted from April 2012 to October 2015 at the Oncology Gynecology Service of the Brazilian National Institute of Cancer (INCA)

Patients ineligible for surgical treatment or presenting non-precocious clinical stage (ASA III and IV evaluation) were excluded from the study. After applying the exclusion criteria, 135 women diagnosed with early stage gynecological cancer (uterine cervix, endometrium, and ovary) submitted to assisted robotic surgery performed through the Da Vinci Si® platform (Sunnyvale, CA Intuitive Surgical) were selected.

Variables such as age, time of surgery, mooring time, length of hospital stay, blood loss in the operative period, number of blood transfusions, the rate of surgery for open surgery and number of dissected lymph nodes were observed through the analysis of medical records.

Results

Of the 135 surgeries studied, there was one case of conversion to laparotomy due to an endometrial stage IV cancer and in five cases of cervical cancer, radical hysterectomies were not performed due to the presence of pelvic lymph nodes positive for malignancy.

11 (8.14%) patients with stages IIIa and IIIb by the Clavien-Dindo Classification required a new surgical intervention. A bladder perforation resulting from the use of a uterine manipulator was treated by robotic surgery but no patient had multiple organ failure or death.

22 procedures had peri-operative complications, 15 were urologic and occurred at the time of bladder detachment, and at the dissection of the ureter and the ureter tunnel during radical hysterectomy. When performing the dissection with bipolar Maryland forceps without triggering the monopolar energy of the scissors in 35W, lesions not noticed in the peri-operative period ceased and no more fistulas occurred.

Furthermore, the use of a 10-fold increase in 3D vision allowed the performance of nerve sparing surgeries (without impairing the bladder branch of the lower hypogastric plexus) and, therefore, avoided complications such as neurogenic bladder and other bladder dysfunctions.

The mean blood loss, length of hospital stay and surgical time were 31.17mL; 1.46 days and 229.66 minutes respectively.

Regarding the types of cancer, most of the surgeries were due to cervical cancer (n=69; 51.11%) followed by endometrial cancer (n=61, 45.18%) and ovarian cancer (n=5, 3.7%). The mean age was 48 years and the BMI 28.84.

The results of the 135 studied cases are shown in table 1. A comparison between this data and other similar studies is displayed in table 2.

Discussion

Robotic surgery and cervix cancer

Radical hysterectomy is the main surgical option for the treatment of early stage carcinoma of the uterine cervix. Because of its complexity, few surgeons perform this surgery by using laparoscopy. Thus, the employment of the robotic technique can result in positive outcomes, as it’s safer, less complex and easier to learn than the traditional laparoscopy [8,9].

Besides that, it’s known that radical hysterectomies performed by the robotic via carry less risk of postoperative complications, bleeding, and infection, and have faster recovery times [10,11].

Average long-term survival is similar between the laparoscopic and the robotic techniques, reaching 95% in 24 months and 97% in 48 months [12]. The number of dissected lymph nodes is generally bigger in the robotic radical hysterectomy [13].

Robotic surgery and endometrial cancer

In gynecologic oncology, robotic surgery is mainly used in the treatment of endometrial cancer. Systematic comparative data between the use of the robotic and the traditional laparoscopic methods is still not available, as the majority of the comparative studies are retrospective.

The benefits of the usage of the robotic over the laparoscopic technique are evident in a major publication by Paley [14]. In this study, 377 patients submitted to robotic hysterectomy had fewer complications and shorter recovery times when compared to 131 patients who underwent laparoscopic hysterectomies.

Robotic surgery and ovarian cancer

The role of the robotic surgery for the treatment of ovarian cancer is still not clear, as there are no comparative papers currently available. With the introduction of the new Da Vinci® XI, new possibilities should be opened in this field, as this machine can now visualize all the 4 operative quadrants.

A retrospective revision work by Feuer et al., [15], comprising of 63 cases demonstrated that, in comparison to the laparoscopic method, the robotic via has: less blood loss, faster postoperative recovery, but longer surgery durations. Complication rates, mean survival time and recurrence risks were not different between the methods.

Conclusions

The occurrence of complications in robotic surgeries is related to factors such as the procedure’s learning curve, the surgeon’s previous laparoscopic experiences, and the mastery of the robotic technique. The appropriate training of the Robotic Team is essential to decrease surgical time and complication rates [16,17].

Complications lead to more hospital visits, readmissions, and delays in hospital discharge. Many of the complications of endometrial cancer operation are due to the clinical condition of the patients, since many of them are obese, hypertensive, or have other comorbidities [18-20].

Robotic tweezers should always be on the surgeon’s sight and the electric activation of the bipolar should always be controlled. If one holds noble structures such as nerves or vessels with an activated bipolar, irreversible damage may occur. Furthermore, the traction on the structures need to be controlled with experience and vision, because the surgeon doesn’t have the tactile feedback [21,22].

The limitation of our study was the lack of comparison with conventional laparoscopy and laparotomies. Thus, a definitive conclusion based on our data is difficult and new prospective studies will be crucial to clarify and demonstrate implications in clinical practice. In spite of this limitation, our data is important due to the number of cases and to the perception that, with practice and time, we can perform complex minimally invasive procedures with great dexterity and safety by the robotic route.

Prospective controlled and randomized studies should evaluate parameters such as postoperative morbidity, the long-term progression of the diseases, and the precise improvement in quality of life [23-26].

Assisted robotic surgery has revolutionized the standard procedures of gynecological surgery, especially in oncological interventions, by reducing postoperative morbidity rates and preserving the basic principles of oncologic surgery.

Finally, technological advances and the development of new therapeutic alternatives indicate that the future of gynecological cancer treatment is promising. Hence the importance of analyzing per and postoperative data of patients submitted to these new techniques.

  1. Robotic Surgery in Gynecologic Cancer (2012) The American College of Obstetricians and Gynecologists 14
  2. Du Pont NC, Chandrasekhar R, Wilding G, Guruka A (2010) Current Trends in Robotic Assisted Surgery: A Survey of Gynecology Oncologists. Int J Med Robot 6: 468-472. Link: https://tinyurl.com/yxfx4sag
  3. Liu H, Lawre Ta, Lu D, Song H, Wang L, et al. (2014) Robotic assisted surgery in gynecology. Cochrane Database Syst Rev. Link: https://tinyurl.com/y4bjbuxu
  4. Ponce J, Barahona M, Maria Jesus P, Rovira J (2016) Robotic Transperitoneal infrarenal para-aortic lymphadenectomy with double docking: technique learning curve and perioperative outcomes. J Minim Invasive Gynecol 23: 622-627. Link: https://tinyurl.com/y4qstkeg
  5. Sinno AK, Fader NA (2014) Robotic assisted surgery in gynecologic oncology. Fertil Steril 102: 922-932. Link: https://tinyurl.com/y5z62hyo
  6. Ramirez PT, Adams S, Boggess JF, Burke WM, Frummovitz MM, et al. (2012) Robotic-assisted surgery in gynecologic oncology: A Society of Gynecologic Oncology consensus statement. Gynecol Oncol 124: 180-184. Link: https://tinyurl.com/y425ualy
  7. Sfakianos GL, Frederick PJ, Kendrick JE, Stranghn JM, Kilgore LC, et al. (2010) Robotic surgery in gynecologic oncology. Fellowship programs in the USA: A survey of fellows and fellowship directors. Int J Med Robotic 6: 405-412. Link: https://tinyurl.com/y22uufz8
  8. Payne TN, Dauterive FR, Pitter MC, Giep BW, Grogg TW, et al. (2010) Robotically assisted hysterectomy in patients with large uteri: outcomes in five community practices. Obstet Gynecol 115: 535-542. Link: https://tinyurl.com/yyqphhmt
  9. Oradyn HA, Nawtal AK, Wegienka G (2012) Comparison of robotic-assisted hysterectomy to other minimally invasive approach. JSLS 16: 542-548. Link: https://tinyurl.com/yyufwnhj
  10. Boggess JF, Gehrig PA, Cantrell L, Shafer A, Ridgway M, et al. (2008) A Case control study of the robot assisted type III. Radical hysterectomy with pelvic lymph node dissection compared with open radical hysterectomy. Am J Obstect Gynecol 199: 357. Link: https://tinyurl.com/y27k722y
  11. Cantrell LA, Mendivil A, Gehrig PA, Boggess JF (2010) Survival outcomes for women undergoing type III robotic radical hysterectomy for cervical cancer: a 3 years experience. Gynecol Oncol 117: 260-265. Link: https://tinyurl.com/y3g8xldc
  12. Tinelli R, Malzoni M, Consentino F, Perone C, Fusco A, et al. (2011) Robotic versus laparoscopic radical hysterectomy with lymphadenectomy in patients with early cervical cancer: a multi-center study. Am Surg Oncol 18: 2622-2628. Link: https://tinyurl.com/y5mhzbs4
  13. De Nardis SA, Holloway RW, Bigsby IV, Pikaart DP, Ahmad S, et al. (2008) Robotically assisted laparoscopic hysterectomy versus total abdominal hysterectomy and lymphadenectomy for endometrial cancer. Gynecol Oncol 111: 412-417. Link: https://tinyurl.com/y3tpw736
  14. Paley PJ, Veljovich DS, Shah CA, Everett EM, Bondurant AE, et al. (2011) Surgical outcomes in gynecologic oncology in the era of Robotics: analysis of the first 1000 cases. Am J Obstet Gynecol 204: 551. Link: https://tinyurl.com/y6hrn38l
  15. Feuer GA, Lakhi N, Barker J, Salmieri S, Burrell M (2013) Perioperative and clinical outcomes in the management of epitelial ovarian cancer using robotic or abdominal approach. Gynecol Oncol 131: 520-524. Link: https://tinyurl.com/yyfspmxe
  16. Seamon LG, Fowler JM, Richardson DL, Carlson MJ, Valmade S, et al. (2009) A detailed analysis of the learning curve: robotic hysterectomy and pelvic aortic lymphadenectomy for endometrial cancer. Gynecol Oncol 114: 162-167. Link: https://tinyurl.com/y36u6wtv
  17. Sandali S, Gadzinski JA, Lee S, Chi DS, Sonoda Y, et al. (2014) Fellowship learning curve associated with completing a robotic assisted total laparoscopic hysterectomy. Gynecol Oncol 132: 102-106. Link: https://tinyurl.com/y4j6g3k5
  18. Boggess JF, Gehrig PA, Cantrell LA, Shafer A, Ridgway M, et al. (2008) A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistencial laparoscopy. Am J Obstet Gynecol 199: 360. Link: https://tinyurl.com/y3dw6ene
  19. Halloway RW, Almad S, De Nardis SA, Peterson BL, Sultana N, et al. (2009) Robotic-assisted laparoscopic hysterectomy and lymphadenectomy for endometrial cancer: analysis of surgical performance. Gynecol Oncol 115: 447-452. Link: https://tinyurl.com/yxl9gobo
  20. Gehrig PA, Cantrell LA, Shafer A, Abaid LN, Mendivil A, et al. (2008) What is for endometrial cancer staging in the obese and morbidly obese woman? Gynecol Oncol 111: 41-45. Link: https://tinyurl.com/y4hqvea3
  21. Veljovich DS, Paley PJ, Drescher CW, Everett EN, Shah C, et al. (2008) Robotic Surgery in Gynecologic Oncology: Program initiation and outcomes after the first year with comparision with laparotomy for endometrial cancer staging. Am J Obstet Gynecol 198: 679. Link: https://tinyurl.com/y629hqve
  22. Person J, Reynisson P, Borg Feldt C, Kannisto P, Lurdahh B, et al. (2009) Robot Assisted Laparoscopic Radical Hysterectomy and pelvic lymphadenectomy with short and long term morbidity data. Gynecol Oncol 113: 185-190. Link: https://tinyurl.com/y4ker67r
  23. Elsahwi KS, Hooper C, De Leon MC, Gallo TN, Ratner E, et al. (2012) Comparison between 155 cases of robotic vs 150 cases of open surgical staging for endometrial cancer. Gynecol Oncol 124: 260-264. Link: https://tinyurl.com/y288uoq7
  24. Coronado PJ, Herratz MA, Magrina JF, Fasero M, Vidart JA (2012) Obst and Gynecol and Reproductive Bio 165: 289-294.
  25. Seror J, Bats AS, Huchon C, Hauser ND, Lécuru F (2014) Laparoscopy vs robotics in surgical management of endometrial cancer: comparison of intraoperative and postoperative complications. J Minim Invasive Gynecol 21: 120-125. Link: https://tinyurl.com/yyhqr8k6
  26. Yim GW, Sang WNN, Jinam KE, Kim S, Kim YT (2015) Perioperative Complications of robot-assisted laparoscopic surgery using three robotic arms at a single institution. Yonsei Medical Journal 56: 474-481. Link: https://tinyurl.com/y4ov3x47
© 2019 Ferreira ÉL, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.